文献速递皮肤肿瘤

评估反射式共聚焦显微镜-光学相干断层扫描联合设备用于基底细胞癌检测和深度评估

Evaluation of a Combined Reflectance Confocal Microscopy-Optical Coherence Tomography Device for Detection and Depth Assessment of Basal Cell Carcinoma.
PubMed 文献 · JAMA Dermatol · 2018-01-01

该试点研究在2017年1月1日至12月31日期间前瞻性连续纳入55例患者的85处皮损,评估RCM-OCT联合探头检测基底细胞癌及评估深部边缘的准确性。既往活检确诊的25处皮损中残留肿瘤检出12处(48%),灵敏度100%、特异度23.1%;既往未活检的60处可疑皮损中诊断基底细胞癌48处(80%),灵敏度100%、特异度75%。OCT估计深度与组织病理测量深度相关,所有皮损R²=0.75。

要点

  • 在既往活检确诊的25处皮损中,RCM-OCT检测残留肿瘤的灵敏度为100%、特异度为23.1%。
  • 在既往未活检的60处可疑皮损中,RCM-OCT诊断基底细胞癌的灵敏度为100%、特异度为75%。
  • OCT估计深度与组织病理测量深度相关,所有皮损R²=0.75(R=0.86,P<.001)。

核心结论

  • 联合RCM-OCT成像可能可前瞻性地用于全面诊断提示基底细胞癌的皮损并分诊治疗。
  • 该设备需在更大队列中进一步验证。

研究设计与样本

  • 试点研究,在纽约州Hauppauge的Memorial Sloan Kettering皮肤癌中心开展。
  • 2017年1月1日至2017年12月31日前瞻性连续纳入55例患者的85处皮损。
  • 患者因医师咨询或Mohs手术转诊,仅纳入成像后有组织病理检查结果者。

主要发现

  • 共对55例患者(女性27例[49%],男性28例[51%],中位年龄59岁[范围21-90岁])的85处皮损进行成像。
  • 成像包括25处既往活检且组织病理确诊的基底细胞癌和60处既往未活检但临床或皮肤镜可疑的皮损。
  • 既往活检皮损中,联合RCM-OCT探头检出12/25处(48%)残留肿瘤,灵敏度100%(95%CI,73.5%-100%),特异度23.1%(95%CI,5.0%-53.8%)。
  • 既往未活检可疑皮损中,诊断48/60处(80%)基底细胞癌,灵敏度100%(95%CI,92.6%-100%),特异度75%(95%CI,42.8%-94.5%)。
  • OCT估计深度与组织病理测量深度相关:所有皮损R²=0.75(R=0.86;P<.001),深度小于500μm皮损R²=0.73(R=0.85;P<.001),深度大于500μm皮损R²=0.65(R=0.43;P<.001)。

临床怎么用

  • 联合RCM-OCT成像可能可前瞻性地用于全面诊断提示基底细胞癌的皮损并分诊治疗。
  • 该设备需在更大队列中进一步验证。

局限性

  • 该设备需在更大队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The limited tissue sampling of a biopsy can lead to an incomplete assessment of basal cell carcinoma (BCC) subtypes and depth. Reflectance confocal microscopy (RCM) combined with optical coherence tomography (OCT) imaging may enable real-time, noninvasive, comprehensive three-dimensional sampling in vivo, which may improve the diagnostic accuracy and margin assessment of BCCs. OBJECTIVE: To determine the accuracy of a combined RCM-OCT device for BCC detection and deep margin assessment. DESIGN, SETTING, AND PARTICIPANTS: This pilot study was carried out on 85 lesions from 55 patients referred for physician consultation or Mohs surgery at Memorial Sloan Kettering Skin Cancer Center in Hauppauge, New York. These patients were prospectively and consecutively enrolled in the study between January 1, 2017, and December 31, 2017. Patients underwent imaging, with the combined RCM-OCT probe, for previously biopsied, histopathologically confirmed BCCs and lesions clinically or dermoscopically suggestive of BCC. Only patients with available histopathologic examination after imaging were included. MAIN OUTCOMES AND MEASURES: Improvements in sensitivity, specificity, and diagnostic accuracy for BCC using the combined RCM-OCT probe as well as the correlation between OCT-estimated depth and histopathologically measured depth were investigated. RESULTS: In total, 85 lesions from 55 patients (27 [49%] were female and 28 [51%] were male with a median [range] age of 59 [21-90] years) were imaged. Imaging was performed on 25 previously biopsied and histopathologically confirmed BCCs and 60 previously nonbiopsied but clinically or dermoscopically suspicious lesions. Normal skin and BCC features were correlated and validated with histopathologic examination. In previously biopsied lesions, residual tumors were detected in 12 of 25 (48%) lesions with 100% sensitivity (95% CI, 73.5%-100%) and 23.1% specificity (95% CI, 5.0%-53.8%) for combined RCM-OCT probe. In previously nonbiopsied and suspicious lesions, BCCs were diagnosed in 48 of 60 (80%) lesions with 100% sensitivity (95% CI, 92.6%-100%) and 75% specificity (95% CI, 42.8%-94.5%). Correlation was observed between depth estimated with OCT and depth measured with histopathologic examination: the coefficient of determination (R2) was 0.75 (R = 0.86; P < .001) for all lesions, 0.73 (R = 0.85; P < .001) for lesions less than 500 μm deep, and 0.65 (R = 0.43; P < .001) for lesions greater than 500 μm deep. CONCLUSIONS AND RELEVANCE: Combined RCM-OCT imaging may be prospectively used to comprehensively diagnose lesions suggestive of BCC and triage for treatment. Further validation of this device must be performed on a larger cohort.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Sahu A, Yélamos O, Iftimia N, et al. Evaluation of a Combined Reflectance Confocal Microscopy-Optical Coherence Tomography Device for Detection and Depth Assessment of Basal Cell Carcinoma. JAMA Dermatol. 2018. PMID: 30140851. doi:10.1001/jamadermatol.2018.2446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。